Brief: NUZ-001 Shows Promise In Zebrafish Model Of Huntington's Disease
16/06/2025 12:43
June 16 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: NUZ-001 SHOWS PROMISE IN ZEBRAFISH MODEL OF HUNTINGTON'S DISEASE NEURIZON THERAPEUTICS LTD - TO INITIATE VALIDATION STUDIES IN MAMMALIAN MODELS OF HUNTINGTON'S DISEASE Source text: ID:nPn5622mYa Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility